Specialties that provided fewer E/M services, such as radiology and general surgery, saw the largest declines, experts wrote in JAMA. 

Mammography screening trends had remained flat, but they fell across all age groups after the USPSTF issued new guidelines in 2009.

CMS first announced the change late last year via the 2023 Outpatient Prospective Payment System/Ambulatory Surgical Center Final Rule. 

The FDA alerted patients and providers about the issue Feb. 15, labeling it as the agency’s “most serious” type of recall. 

The American Society of Neuroradiology and Society of Interventional Radiology want the agency to bust what they say is a burdensome barrier to imaging and other crucial aspects of U.S. medicine.